Susquehanna International Group
PGEN icon

Susquehanna International Group’s Precigen PGEN Stock Holding History

Susquehanna International Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Sell
523,900
-162,200
-24% -$666K ﹤0.01% 6152
2025
Q4 		$2.87M Sell
686,100
-1,491,500
-68% -$5.77M ﹤0.01% 4954
2025
Q3 		$7.16M Buy
2,177,600
+1,954,100
+874% +$5.52M ﹤0.01% 3525
2025
Q2 		$317K Sell
223,500
-722,700
-76% -$1.03M ﹤0.01% 10211
2025
Q1 		$1.41M Buy
946,200
+900,700
+1,980% +$1.42M ﹤0.01% 6371
2024
Q4 		$51K Sell
45,500
-81,900
-64% -$69.9K ﹤0.01% 11670
2024
Q3 		$121K Sell
127,400
-86,300
-40% -$109K ﹤0.01% 10917
2024
Q2 		$338K Buy
213,700
+87,200
+69% +$127K ﹤0.01% 9180
2024
Q1 		$183K Buy
126,500
+103,000
+438% +$148K ﹤0.01% 10694
2023
Q4 		$31.5K Sell
23,500
-2,400
-9% -$2.82K ﹤0.01% 11870
2023
Q3 		$36.8K Buy
25,900
+14,700
+131% +$20.8K ﹤0.01% 11410
2023
Q2 		$12.9K Sell
11,200
-15,400
-58% -$18.2K ﹤0.01% 11720
2023
Q1 		$28.2K Buy
26,600
+3,500
+15% +$5.05K ﹤0.01% 11938
2022
Q4 		$35.1K Sell
23,100
-25,000
-52% -$43K ﹤0.01% 11570
2022
Q3 		$102K Buy
+48,100
New +$101K ﹤0.01% 11691
2022
Q2 		– Sell
-13,900
Closed -$29K – 13679
2022
Q1 		$29K Sell
13,900
-95,200
-87% -$232K ﹤0.01% 12515
2021
Q4 		$405K Sell
109,100
-55,900
-34% -$241K ﹤0.01% 9737
2021
Q3 		$823K Sell
165,000
-37,100
-18% -$214K ﹤0.01% 8062
2021
Q2 		$1.32M Buy
202,100
+48,500
+32% +$339K ﹤0.01% 6998
2021
Q1 		$1.06M Sell
153,600
-28,600
-16% -$242K ﹤0.01% 7590
2020
Q4 		$1.86M Buy
182,200
+61,400
+51% +$398K ﹤0.01% 5251
2020
Q3 		$423K Sell
120,800
-63,900
-35% -$303K ﹤0.01% 8018
2020
Q2 		$922K Buy
184,700
+27,800
+18% +$94.6K ﹤0.01% 6105
2020
Q1 		$533K Sell
156,900
-778,600
-83% -$3.36M ﹤0.01% 6807
2019
Q4 		$5.13M Sell
935,500
-39,300
-4% -$221K ﹤0.01% 2936
2019
Q3 		$5.58M Buy
974,800
+563,300
+137% +$3.83M ﹤0.01% 2581
2019
Q2 		$3.15M Buy
411,500
+66,200
+19% +$356K ﹤0.01% 3374
2019
Q1 		$1.82M Sell
345,300
-60,500
-15% -$419K ﹤0.01% 3909
2018
Q4 		$2.65M Buy
405,800
+53,200
+15% +$596K ﹤0.01% 3097
2018
Q3 		$6.07M Buy
352,600
+148,300
+73% +$2.21M ﹤0.01% 2447
2018
Q2 		$2.85M Sell
204,300
-87,800
-30% -$1.48M ﹤0.01% 3456
2018
Q1 		$4.48M Buy
292,100
+59,500
+26% +$851K ﹤0.01% 2690
2017
Q4 		$2.68M Sell
232,600
-146,400
-39% -$2.18M ﹤0.01% 3416
2017
Q3 		$7.21M Buy
379,000
+33,700
+10% +$694K ﹤0.01% 2093
2017
Q2 		$8.32M Buy
345,300
+131,200
+61% +$2.88M ﹤0.01% 1860
2017
Q1 		$4.24M Sell
214,100
-132,996
-38% -$2.97M ﹤0.01% 2534
2016
Q4 		$8.36M Sell
347,096
-236,207
-40% -$6.58M ﹤0.01% 1736
2016
Q3 		$16.2M Buy
583,303
+286,960
+97% +$7.59M 0.01% 1170
2016
Q2 		$7.23M Sell
296,343
-102,717
-26% -$2.91M ﹤0.01% 1766
2016
Q1 		$13.4M Buy
399,060
+139,041
+53% +$4.38M 0.01% 1290
2015
Q4 		$7.77M Sell
260,019
-223,494
-46% -$7.53M ﹤0.01% 2006
2015
Q3 		$15.2M Buy
483,513
+214,917
+80% +$10.5M 0.01% 1442
2015
Q2 		$13M Sell
268,596
-148,158
-36% -$6.24M 0.01% 1711
2015
Q1 		$18.1M Buy
416,754
+145,440
+54% +$5.23M 0.01% 1311
2014
Q4 		$7.14M Buy
271,314
+107,144
+65% +$2.35M ﹤0.01% 2399
2014
Q3 		$2.92M Sell
164,170
-233,123
-59% -$4.76M ﹤0.01% 3952
2014
Q2 		$9.54M Buy
397,293
+274,977
+225% +$5.57M ﹤0.01% 2169
2014
Q1 		$3.07M Buy
122,316
+59,745
+95% +$1.65M ﹤0.01% 3609
2013
Q4 		$1.42M Buy
62,571
+10,045
+19% +$203K ﹤0.01% 4866
2013
Q3 		$1.19M Buy
+52,526
New +$1.21M ﹤0.01% 4986

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Susquehanna International Group's PGEN Position: Q1 2026 in Review

Susquehanna International Group reduced its Precigen (PGEN) stake by 16% in Q1 2026, selling an estimated $334K and leaving 432,711 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #6582.

Susquehanna International Group first reported a position in PGEN in Q3 2013 and has held it in 49 quarters since. The position peaked at $18.2M in Q4 2015. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Susquehanna International Group held 432,711 shares of Precigen worth $1.67M as of Q1 2026.
  • Susquehanna International Group sold 81,469 Precigen shares in Q1 2026, an estimated $334K.
  • Precigen made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6582 holding.
  • Susquehanna International Group first reported a position in Precigen in Q3 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Precigen position peaked at $18.2M in Q4 2015.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.